title: How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
authors.forename: K
authors.initials: K
authors.lastname: Kaarela
authors.forename: M
authors.initials: M
authors.lastname: Hakala
authors.forename: P
authors.initials: P
authors.lastname: Hannonen
authors.forename: H
authors.initials: H
authors.lastname: Kautiainen
authors.forename: M
authors.initials: M
authors.lastname: Korpela
authors.forename: M
authors.initials: M
authors.lastname: Leirisalo-Repo
authors.forename: R
authors.initials: R
authors.lastname: Luosujärvi
authors.forename: R
authors.initials: R
authors.lastname: Luukkainen
authors.forename: T
authors.initials: T
authors.lastname: Möttönen
authors.forename: K
authors.initials: K
authors.lastname: Puolakka
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine